Adalimumab drug monitoring
Immunology
Sample and container requirements
Serum Li Hep plasma
Minimum volume required
2 ml Blood
Special requirements
none
Patient preparation
None
Sample viability
Store at 4oC prior to sending to referral lab
Turnaround time
21 days
Reference range
Suggested target drug conentrations for Adalimumab in the treatment of IBD: Induction/Post induction: Week 4 Adalimumab concentration to target 8-12 ug/mL Maintenance adalimumab concentration to target 8-12 ug/mL
Clinical guidance
Measurement of Adalimumab is a useful tool in the management of patients who fail to respond ( primary failure) or lose response ( secondary failure) to treatment. Monitoring drug levels allows for a personalised approach to drug optimisation by appropriate dose escalation/de-escalation or drug switching/withdrawal. https://www.synnovis.co.uk/our-tests/adalimumab
Notes
Referred test Synnovis
Images to go here
This information was last updated on 19 August 2026